Home » FDA APPROVES CUBICIN FOR MORE USES
FDA APPROVES CUBICIN FOR MORE USES
The FDA has approved a much broader use for Cubist Pharmaceuticals's Cubicin intravenous antibiotic.
The approval involves expanding Cubicin's indication from skin infections to also treat bloodstream infections, including a form of endocarditis. Cubist said it will begin marketing immediately.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May